Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Multiple MolDX LCDs and Billing and Coding Articles Retirement - Effective March 5, 2026 Mar 05, 2026
Multiple Billing and Coding Articles Retirement - Effective March 5, 2026 Mar 05, 2026
Multiple LCDs and Billing and Coding Articles Retirement - Effective March 5, 2026 Mar 05, 2026
Billing and Coding: Wound and Ulcer Care (A58565) - R12 - Effective October 1, 2025 Mar 05, 2026
Billing and Coding: Botulinum Toxin Injections (A57186) - R12 - Effective March 5, 2026 Mar 05, 2026
Policy Revision(s) for Multiple MolDX Billing and Coding Articles - Effective February 19, 2026 Feb 19, 2026
Billing and Coding: Immune Globulin Intravenous (IVIg) (A57194) - R12 - Effective January 22, 2026 Feb 19, 2026
Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP) (A58223) - R6 - Effective January 1, 2026 Feb 19, 2026
Diagnostic and Therapeutic Colonoscopy (L34213) - R16 - Effective November 6, 2025 Feb 13, 2026
Notice: Allergy Immunotherapy Claims for Venom Allergies Feb 12, 2026
Billing and Coding: Respiratory Care (A57224) - R21 - Effective January 1, 2026 Feb 12, 2026
Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (L38615) - R2 - Effective September 18, 2022 Feb 05, 2026
Sacroiliac Joint Injections and Procedures (L39464) - R1 - Effective March 19, 2023 Feb 05, 2026
Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin (L39398) - R1 - Effective March 5, 2023 Feb 05, 2026
Billing and Coding: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea (A57948) - R10 - Effective January 1, 2026 Feb 05, 2026
Billing and Coding: MolDX: Pharmacogenomics Testing (A57385) - R19 - Effective July 2, 2024 Feb 05, 2026
Multiple MolDX LCDs and Billing and Coding Articles Retirement - Effective February 5, 2026 Feb 05, 2026
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58456) - R16 - Effective Multiple Dates Jan 29, 2026
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57892) - R11 - Effective May 17, 2020 Jan 29, 2026
Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (A58681) - R10 - Effective Multiple Dates Jan 29, 2026